Historically, it has been difficult for cannabis-related businesses to access reliable financial services due to its illegal federal status. Many people wonder if Congress has made any progress in passing legislation to remedy this recently.
The SAFE Banking Act was introduced in 2019 and has passed the House seven times, but it still needs to make it to the Senate floor. Throughout the years, the SAFE Banking Act has been revised and is now referred to as the SAFE Banking Plus Act. This most recent version of the act addresses social equity by including elements related to small business loans, allowing the VA to assist with veterans’ access to medical marijuana and the expungement process outlined in the Harnessing Opportunities by Pursuing Expungement (HOPE) Act.
It would alleviate cannabis companies’ hurdles when looking for financial institutions to lend money. Schumer reassured several times that Congress is “very close” “to introducing and passing the SAFE Banking Act.
On October 30, during a friendly as-can-be debate with Senate Majority Leader Chuck Schumer and Republican challenger Joseph Pinion, the SAFE Banking Act was the topic of discussion. The SAFE Banking Act will provide state and federal protection to financial institutes providing services to cannabis-related businesses.
Joseph Pinion quickly mentioned the lack of movement on the Cannabidiol and Marijuana Research Expansion Act. This bill allows certain registered entities (higher education institutions, practitioners, and manufacturers) to manufacture, distribute, dispense, or possess marijuana or cannabidiol (CBD) for medical research purposes. This bill also directs the DEA to register manufacturers and distributors of CBD or marijuana for commercial production of an approved drug that contains marijuana or its derivative.
Joseph Pinion argued that there was not enough research on the public health risks of cannabis use before lifting the prohibition. Pinion started the rebuttal: “we need to deal with the fact that we’re not talking about your mom and dad’s dope. We’re talking about THC levels that have been off the charts,” he said. Pinion also brought up the consistently debunked rumor of fentanyl-laced cannabis. He stated, “we now have people that are trying to smoke marijuana and are going to drop dead.”
When discussing regulating cannabis at the federal level, Pinion said, “in the event that we’re going to go down this path at the federal level, we should do so in a manner that recognizes that these decisions have dire consequences and that people are actually dying, in some cases, because of them.” Pinion stated “the notion that we would release it on the citizenry at the federal level before we’ve actually done the due diligence seems reckless and irresponsible. Just my thoughts.”
Pinion directed the discussion toward the opioid overdose crisis and illegal drugs coming across the U.S. border. “There are unintended consequences. It is a thread that runneth between all of this, from the border crisis to even this conversation about marijuana, because Chuck Schumer has not taken the business of securing our border, and people are dying.”
Throughout this debate, there was no disagreement that there needs to be more research and resources available to provide the community with safe and well-understood cannabis. How we get to that point is where it gets tricky. Several other cannabis-related legislation and bills will help address the barriers to safe cannabis and address social inequities.
Cannabis Administration and Opportunity Act would end federal cannabis prohibition by removing cannabis from the Controlled Substances Act and empowering states to create cannabis laws. This also would ensure that federal regulation protects public health and safety and prioritize restorative and economic justice.
The Marijuana Opportunity Reinvestment and Expungement (MORE) Act aims to remove cannabis from the Controlled Substance Act (CSA), provide reinvestment opportunities for communities and individuals who have been adversely and disproportionately impacted by the war on drugs, and expunge nonviolent federal cannabis-related convictions. Additionally, the measure would impose a 5% tax on cannabis products and make Small Business Administration (SBA) loans and services available to entities that are legitimate cannabis businesses.
The States Reform Act defers states’ rights for the legalization of cannabis and does not require any form to change or modify its laws on the drug. Additionally, the measure supports federal decriminalization and the release and expungement of any nonviolent, cannabis-only conviction.
The bill aims to regulate cannabis like alcohol and requires the FDA, the U.S. Department of Agriculture (USDA), and the Tax and Trade Bureau, which would be renamed the Alcohol, Tobacco and Cannabis Tax and Trade Bureau, to release guidelines for medical cannabis and policies for growers and producers.
The Drug Policy Reform Act aims to end criminal penalties for drug possession at the federal level and shift regulatory authority from the Department of Justice to Health and Human Services (HHS). This bill explicitly makes HHS responsible for classifying drugs, intending to move toward a more health-centric model. Additionally, the legislation would expunge existing criminal, nonviolent cannabis-related records.
This would address the denial of employment, public benefits, immigration status, driver’s licenses, and voting rights. State courts could enforce the fine; however, it could be waived if an individual cannot afford it.
Looking to find your medical cannabis in a state that hasn’t yet legalized it? It may be tempting to drive across neighboring state lines with more cannabis-friendly laws. However, the number of states that will authorize qualified patients from out-of-state medical marijuana programs is still relatively small. Which States Accept Out-of-State MMJ Cards? States That…
The war on drugs facilitated by the federal government has been an utter failure. Despite cannabis remaining a Schedule I classification according to the federal Controlled Substances Act (CSA), meaning that it has no medicinal value, over 30 states in the United States have legalized it for its medicinal use. While this classification will remain…
Gone are the days when cannabis was just an occasional treat—today, it’s a powerful source of holistic healing. According to a 2021 review published in Current Neuropharmacology, targeting the endocannabinoid system with CBD may offer those affected by borderline personality disorder newfound relief and understanding about managing their condition. What Is Borderline Personality Disorder? Borderline…
Three different types of cannabidiol (CBD) oils produced by Charlotte’s Web have been banned by British regulators. The British Food Standards Agency (FSA) has also disqualified approximately 100 CBD products for undisclosed reasons. In 2018, legislation was passed by the British Parliament that effectively legalized cannabinoids like CBD and CBDA. Despite the law’s passing, CBD…
Bipolar disorder is a complex condition that impacts millions worldwide, leading to extreme mood swings, intense emotional episodes, and difficulty managing day-to-day life. But there may be some good news for those coping with this mental health issue. According to recent research, cannabis could offer unique benefits as part of an approach to managing bipolar…
We sat down with the team at TerraLeaf, a medical cannabis dispensary servicing West Virginia, to ask them the Veriheal 5—five questions…
We all know that cannabis and prednisone can affect our bodies differently when used separately. But if you’re dealing with a pretty…
There’s quite a bit of research supporting cannabis’ effectiveness in reducing anxiety. But did you know that certain strains can actually make…